Cavitation Technologies, Inc.
For the period ended Jun 30, 2026. Filed Oct 6, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed Oct 6, 2026
CVATStored price and day change unavailable
Contents
Signatures
PURSUANT TO THE REQUIREMENTS OF THE SECURITIES EXCHANGE ACT OF 1934, THIS REPORT HAS BEEN SIGNED BELOW BY THE FOLLOWING PERSONS ON BEHALF OF THE REGISTRANT AND IN THE CAPACITIES AND ON THE DATES INDICATED
| SIGNATURE | TITLE | DATE |
|---|---|---|
| /s/ N. Voloshin | President; Member of Board of Directors | October 6, 2026 |
| N. Voloshin | (Principal Executive Officer) | |
| /s/ N. Voloshin | Chief Financial Officer | October 6, 2026 |
| N. Voloshin | (Principal Financial Officer) | |
| /s/ Dr. Gerald Bailey | Independent Director | October 6, 2026 |
| Dr. Gerald Bailey | ||
| /s/ Peter N Christos | Independent Director | October 6, 2026 |
| Peter N. Christos | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.